Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad Trial)

  1. Comely, O.A.
  2. Maertens, J.
  3. Bresnik, M.
  4. Ebrahimi, R.
  5. Ullmann, A.J.
  6. Bouza, E.
  7. Heussel, C.P.
  8. Lorttiolary, O.
  9. Rieger, C.
  10. Boehrne, A.
  11. Aoun, M.
  12. Horst, H.-A.
  13. Thiebaut, A.
  14. Ruhnke, M.
  15. Raicfoert, D.
  16. Vianelli, N.
  17. Krause, S.W.
  18. Olavarria, E.
  19. Herbrecht, R.
Aldizkaria:
Clinical Infectious Diseases

ISSN: 1058-4838

Argitalpen urtea: 2007

Alea: 44

Zenbakia: 10

Orrialdeak: 1289-1297

Mota: Artikulua

DOI: 10.1086/514341 GOOGLE SCHOLAR lock_openSarbide irekia editor